Low back pain
Conditions
Interventions
This is a randomized, controlled, double-blind clinical trial with two groups. Control group: 18 people with non-specific chronic low back pain that will receive the ILIB EC-DMC therapy in a placebo f
Sponsors
Laboratório de Avaliação Funcional e Performance Motora Humana - LAFUP
Laboratório de Avaliação Funcional e Performance Motora Humana - LAFUP
Eligibility
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Present age between 18-35 years; both genders; nonspecific chronic low back pain; volunteer; belong to Londrina (PR)
Exclusion criteria
Exclusion criteria: Neurological disease; cardiorespiratory disease; vascular disease; metabolic disease; high-severity orthopedic disease; loss of balance; labyrinthine crises; epileptic seizures; convulsive crises; mental issue; attention and speech disorders; use vasodilators and/or anticoagulants; use anti-inflammatory drugs and/or analgesics and/or muscle relaxants in the last week; photosensitivity. dermatitis; presence of tattoo in the area and/or lymphedema, cancer; pregnancy; spine and/or locomotor system surgery; perform physiotherapeutic treatment during the research; not present inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find an improvement in nonspecific chronic low back pain with the use of the ILIB method. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected to see an improvement in balance in patients with nonspecific chronic low back pain after the application of ILIB, as well as in functional scales, pain and muscle pattern. | — |
Countries
Brazil
Contacts
Public ContactRodrigo Antônio Andraus
Universidade Norte do Paraná
Outcome results
None listed